Gehad M. Subaiea, Ph.D.
Affiliations: | 2013 | Pharmaceutical Sciences | University of Rhode Island, Providence, RI, United States |
Area:
Pharmacology, Behavioral Psychology, Neuroscience Biology, Cognitive PsychologyGoogle:
"Gehad Subaiea"Mean distance: 35622
Parents
Sign in to add mentor| Nasser Zawia | grad student | 2013 | University of Rhode Island | |
| (Brain penetration of tolfenamic acid and its ability to enhance the cognitive functions and to lower amyloid pathology in animal mouse models of Alzheimer's disease.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bihaqi SW, Alansi B, Masoud AM, et al. (2018) Influence of Early Life Lead (Pb) exposure on α-Synuclein, GSK-3β and Caspase-3 mediated Tauopathy: Implications on Alzheimer's disease. Current Alzheimer Research |
| Masoud AM, Bihaqi SW, Alansi B, et al. (2018) Altered microRNA, mRNA, and Protein Expression of Neurodegeneration-Related Biomarkers and Their Transcriptional and Epigenetic Modifiers in a Human Tau Transgenic Mouse Model in Response to Developmental Lead Exposure. Journal of Alzheimer's Disease : Jad |
| Chang JK, Leso A, Subaiea GM, et al. (2018) Tolfenamic acid: A modifier of the tau protein and its role in cognition and tauopathy. Current Alzheimer Research |
| Dash M, Eid A, Subaiea G, et al. (2016) Developmental exposure to lead (Pb) alters the expression of the Human Tau Gene and its products in a transgenic animal model. Neurotoxicology |
| Adwan L, Subaiea GM, Basha R, et al. (2015) Tolfenamic acid reduces tau and CDK5 levels: implications for dementia and tauopathies. Journal of Neurochemistry. 133: 266-72 |
| Subaiea GM, Ahmed AH, Adwan LI, et al. (2015) Reduction of amyloid-β deposition and attenuation of memory deficits by tolfenamic acid. Journal of Alzheimer's Disease : Jad. 43: 425-33 |
| Ahmed AH, Subaiea GM, Eid A, et al. (2014) Pomegranate extract modulates processing of amyloid-β precursor protein in an aged Alzheimer's disease animal model. Current Alzheimer Research. 11: 834-43 |
| Adwan L, Subaiea GM, Zawia NH. (2014) Tolfenamic acid downregulates BACE1 and protects against lead-induced upregulation of Alzheimer's disease related biomarkers. Neuropharmacology. 79: 596-602 |
| Bihaqi SW, Bahmani A, Subaiea GM, et al. (2014) Infantile exposure to lead and late-age cognitive decline: relevance to AD. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 187-95 |
| Subaiea GM, Adwan LI, Ahmed AH, et al. (2013) Short-term treatment with tolfenamic acid improves cognitive functions in Alzheimer's disease mice. Neurobiology of Aging. 34: 2421-30 |